Donald Wuchterl
Director/Board Member at ABEONA THERAPEUTICS INC.
Net worth: 545 033 $ as of 2024-03-30
Profile
Donald A.
Wuchterl is an Independent Director at Abeona Therapeutics, Inc. and Senior VP & Chief Manufacturing Officer at T-Knife Therapeutics, Inc. He was previously the Chief Operating Officer & Senior Vice President at Cytovance Biologics, Inc. and Senior VP-Technical Operations & Quality at Astellas Gene Therapies, Inc. He holds an undergraduate degree from Colorado Technical University, Inc. and an MBA from Fitchburg State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 75,177 ( 0.27% ) | 545 033 $ | 2024-03-30 |
Donald Wuchterl active positions
| Companies | Position | Start |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2021-04-18 |
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | - |
Former positions of Donald Wuchterl
| Companies | Position | End |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-12-31 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Chief Operating Officer | - |
Training of Donald Wuchterl
| Colorado Technical University, Inc. | Undergraduate Degree |
| Fitchburg State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
| T-Knife Therapeutics, Inc. |
- Stock Market
- Insiders
- Donald Wuchterl
